ESC Premium Access

Early commencement of tolvaptan therapy improves clinical outcomes in heart failure patients with preserved function of renal vasopressin V2 receptors

Congress Presentation

About the speaker

Doctor Takahiro Noto

Sapporo Medical University, Sapporo (Japan)
0 follower

7 more presentations in this session

Research into the effect of sodium-glucose linked transporter inhibition in left ventricular remodelling in patients with heart failure and diabetes mellitus.

Speaker: Professor C. Lang (Dundee, GB)


Diminished response to statin therapy predicts future occurrence of heart failure in patients with acute myocardial infarction

Speaker: Doctor K. Tsuda (Takatsuki, JP)


Titration patterns and clinical characteristics of patients prescribed sacubitril/valsartan in the primary care and cardiology settings in germany

Speaker: Associate Professor R. Wachter (Leipzig, DE)


Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Speaker: Professor U. Zeymer (Ludwigshafen, DE)


Heart rate reduction by selective sinus node blocker (ivabradine) protects against detrimental hemodynamic and structural effects of iv inotrops in heart failure

Speaker: Professor P. Leszek (Warsaw, PL)


Access the full session

Poster Session 1 - Chronic heart failure – Treatment

Speakers: Doctor T. Noto, Professor C. Lang, Doctor K. Tsuda, Associate Professor R. Wachter, Professor U. Zeymer...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb